Boston, MA -- (SBWIRE) -- 09/12/2013 -- Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner.Chartpoppers.com issues news alert on the following stocks:- PT BK MANDIRI PE ADR(OTCMKTS:PPERY), Epazz Inc(OTCMKTS:EPAZ), ELECTRICITE DE FRANC(OTCMKTS:ECIFY), Avanir Pharmaceuticals Inc(NASDAQ:AVNR)
PT BK MANDIRI PE ADR(OTCMKTS:PPERY), during the previous trading period, showed a positive activity of +0.43%. Currently, the company has a market capital of $16.19 billion dollars. The stock’s final trade was made at $6.97, while it had started its day-trade at $6.99. In the past 52-week period, the stock has not gone below $5.70 and traded at maximum level of $11.06. PT Bank Mandiri (Persero) Tbk, together with its subsidiaries, engages in institutional and corporate banking, commercial and business banking, consumer finance, micro and retail banking, and treasury, financial institution, and special asset management businesses in Indonesia.
For How Long PPERY will Fight for Profitability? Read This Trend Analysis report
Epazz Inc(OTCMKTS:EPAZ) completed latest trade+9.09% higher at $0.0012 from prior close of $0.0011. It was exchanged between $0.001– 0.0014 with 25.75 in overall exchanged numbers of shares. Epazz, Inc., together with its subsidiaries, designs and sells various software programs to business enterprises, hospitals, and government and post-secondary institutions in the United States.
For How Long EPAZ’s Gloss will Attract Investors? Find out via this report
ELECTRICITE DE FRANC(OTCMKTS:ECIFY) decreased -0.52% to close at $5.74in the last trading session and its total traded volume was 115,371.00 shares versus average volume of 58,989.00. The company has market cap of $53.66 billion.
The stock has positive year-to-date performance of +54.72% while its quarterly performance remained +20.84%. Electricité de France S.A., an integrated energy company, engages in the generation, transmission, distribution, supply, and trading of energies in France and internationally.
Why Should Investors Buy ECIFY After the Recent Fall? Just Go Here and Find Out
Avanir Pharmaceuticals Inc(NASDAQ:AVNR) declined -13.38% to end at $4.79 and its overall volume in the last trading session was 16.6 million shares, versus average trading volume of 2.72 million. It has market cap of $696.80 million while its total outstanding shares are 145.47 million.
The stock gained/declined 50.00% in this year and reported the loss/gainof -60.00% in the last 5 days. The stock 3 month performance stands at 1.12%. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
Chartpoppers.com spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit chartpoppers right now and see what it’s all about for yourself! At 50,000 Visitors a Month and growing rapidly chartpoppers is the hottest thing in Penny Stocks!
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ChartPoppers.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ChartPoppers.com is owned and operated by One22 Media,LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ChartPoppers’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ChartPoppers or an offer or solicitation to buy or sell any security. Neither the owner of ChartPoppers nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters.
Read Full Disclaimer at: http://chartpoppers.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)